SOSV is a global venture capital firm based in Princeton, New Jersey, founded in 1995. It specializes in early-stage investments, focusing on deep technology innovations that address human and planetary health. The firm operates startup development programs, notably HAX and IndieBio, which provide resources, facilities, and lab equipment to accelerate the growth of promising startups. SOSV supports companies from their inception through various funding stages, including seed and series A rounds, while offering ongoing assistance to help them scale and attract additional investors. By concentrating on revolutionary technologies and cross-border markets, particularly in Asia, SOSV aims to foster significant advancements that benefit humanity and the environment.
Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016 and based in Barcelona, Spain, the company specializes in creating non-invasive tests for the in-situ diagnosis of various cancers using patients' blood. It also develops in-vivo diagnosis systems that assist in surgical procedures and monitor patient conditions, alongside therapeutical drugs aimed at treating cancer. Moirai Biodesign's innovative pipeline includes RNA biomarker discovery, the design of plug-and-play bio devices, and advanced platform delivery systems, all aimed at improving early cancer detection and targeted treatment options.
Impedans specializes in intelligent sensing platforms for radio-frequency (RF) and plasma process monitoring. Their technology is utilized across various sectors, including semiconductor manufacturing, vacuum coating, medical devices, hard disk production, and aerospace, among others. The company's products support applications such as fundamental research, process development, tool design, process control, and fault detection and classification. By offering high-resolution plasma diagnostics and quality performance, Impedans enables clients to obtain accurate process measurements and address complex processing challenges effectively. Their expertise in RF and plasma systems, combined with internet-enabled sensing capabilities, provides an independent diagnosis of process health, helping customers optimize their operations.
Hexafly is a biotechnology company based in Kells, Ireland, that focuses on developing sustainable products derived from the farming of Black Soldier Fly larvae. Established in 2016, Hexafly operates within the circular economy by converting food waste into valuable resources, including insect oil and protein for aquaculture and animal feed, as well as Frass, a plant nutrition compound. The company also produces Chitin, a biopolymer used in pharmaceuticals, cosmetics, and food additives. By offering these products online, Hexafly aims to provide sustainable solutions for the aquaculture, animal feed, and plant nutrition industries, contributing to a more sustainable food system for animals and, ultimately, humans.
Impedans specializes in intelligent sensing platforms for radio-frequency (RF) and plasma process monitoring. Their technology is utilized across various sectors, including semiconductor manufacturing, vacuum coating, medical devices, hard disk production, and aerospace, among others. The company's products support applications such as fundamental research, process development, tool design, process control, and fault detection and classification. By offering high-resolution plasma diagnostics and quality performance, Impedans enables clients to obtain accurate process measurements and address complex processing challenges effectively. Their expertise in RF and plasma systems, combined with internet-enabled sensing capabilities, provides an independent diagnosis of process health, helping customers optimize their operations.
Ostoform is a spin-out medical device company from the University of Limerick, Ireland with a range of patented technologies, and the potential to scale, becoming a global leader in the area of ostomy skin health.
Intelligent Implants, founded in 2014 in Cork, Ireland, specializes in the development of wireless implantable electronics designed to stimulate, steer, and monitor bone growth. The company focuses on creating electrotherapeutic devices that not only treat diseases but also support the recovery of bone and other tissues. By integrating data, engineering, and medicine, Intelligent Implants aims to deliver innovative, active, and connected medical devices that enhance patient treatment and facilitate decision-making for healthcare professionals. Their technology allows for the acceleration and adjustment of bone growth, enabling healthcare providers to effectively utilize electrotherapeutics to monitor and control patient conditions, ultimately leading to more timely and informed medical interventions.
Plantruption builds a brand of sustainability to develop products using seaweed and microalgae. The company is on a mission to create the first plant-based seafood. It researches and collaborates with universities and food technologists to provides Plant-based seafood that’s close in taste and texture to the real deal. Plant-based seafood provides a host of environmental benefits, including alleviating pressures on rapidly depleting fisheries, providing relief to fragile ocean ecosystems, reducing the impact of fishing nets on the ocean plastic problem, and reducing production emissions. The company was founded in 2019 in Dublin, Dublin.
Aylien is an artificial intelligence company based in Wilmington, Delaware, specializing in technologies that enhance machines' understanding of human languages. The firm provides a suite of tools and APIs, including Text Analysis and News APIs, which help users analyze and extract insights from large volumes of human-generated content. Aylien's offerings cater to developers, data scientists, marketers, and academics, enabling them to utilize advanced techniques like natural language processing, machine learning, and image recognition. Among its key products are Talk.ee, which organizes global information, and the AYLIEN App Engine, an open platform for creating micro applications that convert unstructured data into structured formats. Additionally, Aylien offers oTaste, a tool aimed at digitizing human tastes, further demonstrating its commitment to innovative data solutions.
Intelligent Implants, founded in 2014 in Cork, Ireland, specializes in the development of wireless implantable electronics designed to stimulate, steer, and monitor bone growth. The company focuses on creating electrotherapeutic devices that not only treat diseases but also support the recovery of bone and other tissues. By integrating data, engineering, and medicine, Intelligent Implants aims to deliver innovative, active, and connected medical devices that enhance patient treatment and facilitate decision-making for healthcare professionals. Their technology allows for the acceleration and adjustment of bone growth, enabling healthcare providers to effectively utilize electrotherapeutics to monitor and control patient conditions, ultimately leading to more timely and informed medical interventions.
Plantruption builds a brand of sustainability to develop products using seaweed and microalgae. The company is on a mission to create the first plant-based seafood. It researches and collaborates with universities and food technologists to provides Plant-based seafood that’s close in taste and texture to the real deal. Plant-based seafood provides a host of environmental benefits, including alleviating pressures on rapidly depleting fisheries, providing relief to fragile ocean ecosystems, reducing the impact of fishing nets on the ocean plastic problem, and reducing production emissions. The company was founded in 2019 in Dublin, Dublin.
Hexafly is a biotechnology company based in Kells, Ireland, that focuses on developing sustainable products derived from the farming of Black Soldier Fly larvae. Established in 2016, Hexafly operates within the circular economy by converting food waste into valuable resources, including insect oil and protein for aquaculture and animal feed, as well as Frass, a plant nutrition compound. The company also produces Chitin, a biopolymer used in pharmaceuticals, cosmetics, and food additives. By offering these products online, Hexafly aims to provide sustainable solutions for the aquaculture, animal feed, and plant nutrition industries, contributing to a more sustainable food system for animals and, ultimately, humans.
Lios, originally founded as Restored Hearing in 2009 by Rhona Togher and Eimear O’Carroll, focuses on combating noise pollution through innovative materials and technologies. The company specializes in developing solutions that reduce the risk of exposure to loud noise and mitigate damage from it. Its flagship product, SoundBounce, is a revolutionary acoustic material designed for various industries, including automotive, aerospace, construction, and power generation. SoundBounce is notably thinner and more effective than traditional soundproofing materials. Additionally, Lios offers SoundRelief, a tinnitus sound therapy app available on both Apple and Android platforms, which provides at-home treatment for ringing in the ears. The app, scientifically validated and CE marked, includes features for tracking tinnitus and has been utilized in over 60 countries, significantly improving users' quality of life. Through these innovations, Lios addresses industry challenges with a commitment to creating a quieter world.
Kite Medical has created an innovative device designed to detect kidney reflux in children experiencing urinary tract infections. This non-invasive diagnostic solution simplifies the detection process, eliminating the need for complex procedures and hospital visits. Kidney reflux, the most common urological disorder in childhood, affects up to three percent of young children, particularly those aged six months to five years. While the condition may resolve as children grow, undiagnosed and untreated cases can lead to serious consequences, including permanent kidney damage and kidney failure. By providing a straightforward and accessible means of diagnosis, Kite Medical aims to improve the management of this prevalent condition in pediatric patients.
Plantruption builds a brand of sustainability to develop products using seaweed and microalgae. The company is on a mission to create the first plant-based seafood. It researches and collaborates with universities and food technologists to provides Plant-based seafood that’s close in taste and texture to the real deal. Plant-based seafood provides a host of environmental benefits, including alleviating pressures on rapidly depleting fisheries, providing relief to fragile ocean ecosystems, reducing the impact of fishing nets on the ocean plastic problem, and reducing production emissions. The company was founded in 2019 in Dublin, Dublin.
FoodMarble is a company that addresses the challenges faced by nearly one billion individuals with disruptive digestive symptoms. Its flagship product, AIRE, is a personal breath analyzer designed to help users identify which foods are best suited to their unique digestive systems. By utilizing a handheld device and a companion application, AIRE allows individuals to monitor their digestion in real time, leveraging techniques commonly employed in gastroenterology. This innovative approach empowers users to develop personalized diets that can alleviate discomfort and improve their overall well-being. Since its inception, FoodMarble has garnered significant interest, receiving over $500,000 in pre-orders prior to the commencement of device shipments in late 2017. The company aims to create the first comprehensive dataset of its kind, further enhancing users' ability to manage their digestive health.
Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016 and based in Barcelona, Spain, the company specializes in creating non-invasive tests for the in-situ diagnosis of various cancers using patients' blood. It also develops in-vivo diagnosis systems that assist in surgical procedures and monitor patient conditions, alongside therapeutical drugs aimed at treating cancer. Moirai Biodesign's innovative pipeline includes RNA biomarker discovery, the design of plug-and-play bio devices, and advanced platform delivery systems, all aimed at improving early cancer detection and targeted treatment options.
FoodMarble is a company that addresses the challenges faced by nearly one billion individuals with disruptive digestive symptoms. Its flagship product, AIRE, is a personal breath analyzer designed to help users identify which foods are best suited to their unique digestive systems. By utilizing a handheld device and a companion application, AIRE allows individuals to monitor their digestion in real time, leveraging techniques commonly employed in gastroenterology. This innovative approach empowers users to develop personalized diets that can alleviate discomfort and improve their overall well-being. Since its inception, FoodMarble has garnered significant interest, receiving over $500,000 in pre-orders prior to the commencement of device shipments in late 2017. The company aims to create the first comprehensive dataset of its kind, further enhancing users' ability to manage their digestive health.
GlowDx is a diagnostics company based in Midleton, Ireland, established in 2015. The company focuses on decentralizing molecular testing through innovative point-of-care technologies, which facilitate local access to diagnostics for tropical diseases. By combining novel molecular technology with effective delivery models, GlowDx aims to improve clinical outcomes while reducing the economic burden on patients and healthcare systems. This approach enhances the quality of life for individuals by ensuring they receive timely and accurate diagnostic information, thereby enabling healthcare providers to offer better-targeted treatments.
Hexafly is a biotechnology company based in Kells, Ireland, that focuses on developing sustainable products derived from the farming of Black Soldier Fly larvae. Established in 2016, Hexafly operates within the circular economy by converting food waste into valuable resources, including insect oil and protein for aquaculture and animal feed, as well as Frass, a plant nutrition compound. The company also produces Chitin, a biopolymer used in pharmaceuticals, cosmetics, and food additives. By offering these products online, Hexafly aims to provide sustainable solutions for the aquaculture, animal feed, and plant nutrition industries, contributing to a more sustainable food system for animals and, ultimately, humans.
Metabolomic Diagnostics Ltd. is a medical diagnostics company based in Little Island, Ireland, founded in 2011. The company specializes in developing advanced diagnostic solutions that utilize mass spectrometry technology to analyze biomarkers associated with complex diseases. Its primary focus is on providing predictive diagnoses for pre-eclampsia in early pregnancy through a blood test that assesses the risk of this condition, which can lead to serious complications such as hypertension and restricted blood flow to the fetus. Metabolomic Diagnostics has established a pipeline for identifying diagnostic biomarker panels and translating these findings into clinical assays suitable for use in laboratory settings, thus enabling effective disease diagnosis and risk prediction.
OaCP specializes in healthcare technology focused on enhancing cancer diagnosis through innovative molecular in vitro diagnostics. The company offers patented chemical reagents that significantly reduce both the time and cost associated with DNA testing for cancer, achieving a 97% reduction in time and a 50% reduction in costs. Operating within the competitive USD 1 billion in situ hybridization market, OaCP has recorded USD 100,000 in sales and maintains a strong customer retention rate and gross margin. Its distribution network spans nearly 15 countries, serving hospitals and research and development centers. The company has participated in the RebelBio Accelerator program and secured funding of USD 330,000 from SOS Venture. OaCP has received recognition in various international competitions, particularly in Hong Kong and China. Currently, the company seeks an investment of EUR 2 million to further expand its market presence and develop its diagnostic technology, ultimately aiming to improve the quality of life for cancer patients.
Lios, originally founded as Restored Hearing in 2009 by Rhona Togher and Eimear O’Carroll, focuses on combating noise pollution through innovative materials and technologies. The company specializes in developing solutions that reduce the risk of exposure to loud noise and mitigate damage from it. Its flagship product, SoundBounce, is a revolutionary acoustic material designed for various industries, including automotive, aerospace, construction, and power generation. SoundBounce is notably thinner and more effective than traditional soundproofing materials. Additionally, Lios offers SoundRelief, a tinnitus sound therapy app available on both Apple and Android platforms, which provides at-home treatment for ringing in the ears. The app, scientifically validated and CE marked, includes features for tracking tinnitus and has been utilized in over 60 countries, significantly improving users' quality of life. Through these innovations, Lios addresses industry challenges with a commitment to creating a quieter world.
Aylien is an artificial intelligence company based in Wilmington, Delaware, specializing in technologies that enhance machines' understanding of human languages. The firm provides a suite of tools and APIs, including Text Analysis and News APIs, which help users analyze and extract insights from large volumes of human-generated content. Aylien's offerings cater to developers, data scientists, marketers, and academics, enabling them to utilize advanced techniques like natural language processing, machine learning, and image recognition. Among its key products are Talk.ee, which organizes global information, and the AYLIEN App Engine, an open platform for creating micro applications that convert unstructured data into structured formats. Additionally, Aylien offers oTaste, a tool aimed at digitizing human tastes, further demonstrating its commitment to innovative data solutions.
Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016 and based in Barcelona, Spain, the company specializes in creating non-invasive tests for the in-situ diagnosis of various cancers using patients' blood. It also develops in-vivo diagnosis systems that assist in surgical procedures and monitor patient conditions, alongside therapeutical drugs aimed at treating cancer. Moirai Biodesign's innovative pipeline includes RNA biomarker discovery, the design of plug-and-play bio devices, and advanced platform delivery systems, all aimed at improving early cancer detection and targeted treatment options.
Intelligent Implants, founded in 2014 in Cork, Ireland, specializes in the development of wireless implantable electronics designed to stimulate, steer, and monitor bone growth. The company focuses on creating electrotherapeutic devices that not only treat diseases but also support the recovery of bone and other tissues. By integrating data, engineering, and medicine, Intelligent Implants aims to deliver innovative, active, and connected medical devices that enhance patient treatment and facilitate decision-making for healthcare professionals. Their technology allows for the acceleration and adjustment of bone growth, enabling healthcare providers to effectively utilize electrotherapeutics to monitor and control patient conditions, ultimately leading to more timely and informed medical interventions.
MicroSynbiotiX Limited is a biotechnology company based in Cork City, Ireland, that specializes in developing oral vaccines tailored for the aquaculture sector. Founded in 2016, the company focuses on addressing the challenges posed by excessive antibiotic use in farmed fish. Through advancements in algal genomics and molecular biology, MicroSynbiotiX engineers microalgae to produce cost-effective therapeutic proteins and vaccines. This innovative approach utilizes microalgae as an oral delivery system, significantly reducing production costs and labor associated with traditional vaccine methods. The technology aims to decrease fish mortality rates, prevent bacterial and viral diseases that threaten fish stocks, and enhance global food security by providing affordable and user-friendly solutions for aquaculture.
Sothic Bioscience Ltd. is a biotech company based in Cork, Ireland, established in 2015. The company focuses on developing LimuleX, a bio-production platform designed to create bio-identical replacements for naturally sourced limulus amebocyte lysate. This innovation aims to eliminate the reliance on the threatened horseshoe crab species in the pharmaceutical quality control supply chain. Sothic Bioscience is currently in the lab bench production phase of a highly specific pyrogen contamination testing reagent. To support scaling up production and market entry, the company is actively raising seed capital, emphasizing its commitment to replacing unsustainable animal sourcing with scalable production of high-quality biomolecules for the pharmaceutical, medical device, and biomedical research sectors.
FoodMarble is a company that addresses the challenges faced by nearly one billion individuals with disruptive digestive symptoms. Its flagship product, AIRE, is a personal breath analyzer designed to help users identify which foods are best suited to their unique digestive systems. By utilizing a handheld device and a companion application, AIRE allows individuals to monitor their digestion in real time, leveraging techniques commonly employed in gastroenterology. This innovative approach empowers users to develop personalized diets that can alleviate discomfort and improve their overall well-being. Since its inception, FoodMarble has garnered significant interest, receiving over $500,000 in pre-orders prior to the commencement of device shipments in late 2017. The company aims to create the first comprehensive dataset of its kind, further enhancing users' ability to manage their digestive health.
Hexafly is a biotechnology company based in Kells, Ireland, that focuses on developing sustainable products derived from the farming of Black Soldier Fly larvae. Established in 2016, Hexafly operates within the circular economy by converting food waste into valuable resources, including insect oil and protein for aquaculture and animal feed, as well as Frass, a plant nutrition compound. The company also produces Chitin, a biopolymer used in pharmaceuticals, cosmetics, and food additives. By offering these products online, Hexafly aims to provide sustainable solutions for the aquaculture, animal feed, and plant nutrition industries, contributing to a more sustainable food system for animals and, ultimately, humans.
GlowDx is a diagnostics company based in Midleton, Ireland, established in 2015. The company focuses on decentralizing molecular testing through innovative point-of-care technologies, which facilitate local access to diagnostics for tropical diseases. By combining novel molecular technology with effective delivery models, GlowDx aims to improve clinical outcomes while reducing the economic burden on patients and healthcare systems. This approach enhances the quality of life for individuals by ensuring they receive timely and accurate diagnostic information, thereby enabling healthcare providers to offer better-targeted treatments.
Intelligent Implants, founded in 2014 in Cork, Ireland, specializes in the development of wireless implantable electronics designed to stimulate, steer, and monitor bone growth. The company focuses on creating electrotherapeutic devices that not only treat diseases but also support the recovery of bone and other tissues. By integrating data, engineering, and medicine, Intelligent Implants aims to deliver innovative, active, and connected medical devices that enhance patient treatment and facilitate decision-making for healthcare professionals. Their technology allows for the acceleration and adjustment of bone growth, enabling healthcare providers to effectively utilize electrotherapeutics to monitor and control patient conditions, ultimately leading to more timely and informed medical interventions.
CyCa OncoSolutions Pvt. Ltd. is a technology company focused on developing molecular devices for the targeted delivery of anticancer drugs directly into cells. Established in 2017 and based in Balasore, India, the company has created innovative drug delivery systems that can cross cellular membrane bilayers, facilitating the introduction of functional molecules such as anticancer agents, water-soluble dyes, and imaging agents into the cytoplasm and other organelles. This technology is particularly beneficial for pharmaceutical and biotechnology companies, as it enhances the brand lifecycle of their drugs and molecules by improving delivery efficacy.
Helixworks is a biotechnology company focused on advancing the field of synthetic biology through innovative enzymatic DNA synthesis methods. The company aims to simplify the complexities of DNA data storage, providing a comprehensive platform that equips developers with essential tools and services. This infrastructure supports various applications, including molecular tagging, digital preservation, and traditional media. Additionally, Helixworks offers advanced barcoding kits designed for multiplexed Next-Generation Sequencing (NGS) applications, which enhance the efficiency and accuracy of sequencing projects. The company's overarching goal is to enable the engineering of living machines, thereby transforming biology into an engineering discipline.
MicroSynbiotiX Limited is a biotechnology company based in Cork City, Ireland, that specializes in developing oral vaccines tailored for the aquaculture sector. Founded in 2016, the company focuses on addressing the challenges posed by excessive antibiotic use in farmed fish. Through advancements in algal genomics and molecular biology, MicroSynbiotiX engineers microalgae to produce cost-effective therapeutic proteins and vaccines. This innovative approach utilizes microalgae as an oral delivery system, significantly reducing production costs and labor associated with traditional vaccine methods. The technology aims to decrease fish mortality rates, prevent bacterial and viral diseases that threaten fish stocks, and enhance global food security by providing affordable and user-friendly solutions for aquaculture.
Hexafly is a biotechnology company based in Kells, Ireland, that focuses on developing sustainable products derived from the farming of Black Soldier Fly larvae. Established in 2016, Hexafly operates within the circular economy by converting food waste into valuable resources, including insect oil and protein for aquaculture and animal feed, as well as Frass, a plant nutrition compound. The company also produces Chitin, a biopolymer used in pharmaceuticals, cosmetics, and food additives. By offering these products online, Hexafly aims to provide sustainable solutions for the aquaculture, animal feed, and plant nutrition industries, contributing to a more sustainable food system for animals and, ultimately, humans.
Intelligent Implants, founded in 2014 in Cork, Ireland, specializes in the development of wireless implantable electronics designed to stimulate, steer, and monitor bone growth. The company focuses on creating electrotherapeutic devices that not only treat diseases but also support the recovery of bone and other tissues. By integrating data, engineering, and medicine, Intelligent Implants aims to deliver innovative, active, and connected medical devices that enhance patient treatment and facilitate decision-making for healthcare professionals. Their technology allows for the acceleration and adjustment of bone growth, enabling healthcare providers to effectively utilize electrotherapeutics to monitor and control patient conditions, ultimately leading to more timely and informed medical interventions.
Ostoform is a spin-out medical device company from the University of Limerick, Ireland with a range of patented technologies, and the potential to scale, becoming a global leader in the area of ostomy skin health.
CyCa OncoSolutions Pvt. Ltd. is a technology company focused on developing molecular devices for the targeted delivery of anticancer drugs directly into cells. Established in 2017 and based in Balasore, India, the company has created innovative drug delivery systems that can cross cellular membrane bilayers, facilitating the introduction of functional molecules such as anticancer agents, water-soluble dyes, and imaging agents into the cytoplasm and other organelles. This technology is particularly beneficial for pharmaceutical and biotechnology companies, as it enhances the brand lifecycle of their drugs and molecules by improving delivery efficacy.
Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016 and based in Barcelona, Spain, the company specializes in creating non-invasive tests for the in-situ diagnosis of various cancers using patients' blood. It also develops in-vivo diagnosis systems that assist in surgical procedures and monitor patient conditions, alongside therapeutical drugs aimed at treating cancer. Moirai Biodesign's innovative pipeline includes RNA biomarker discovery, the design of plug-and-play bio devices, and advanced platform delivery systems, all aimed at improving early cancer detection and targeted treatment options.
OaCP specializes in healthcare technology focused on enhancing cancer diagnosis through innovative molecular in vitro diagnostics. The company offers patented chemical reagents that significantly reduce both the time and cost associated with DNA testing for cancer, achieving a 97% reduction in time and a 50% reduction in costs. Operating within the competitive USD 1 billion in situ hybridization market, OaCP has recorded USD 100,000 in sales and maintains a strong customer retention rate and gross margin. Its distribution network spans nearly 15 countries, serving hospitals and research and development centers. The company has participated in the RebelBio Accelerator program and secured funding of USD 330,000 from SOS Venture. OaCP has received recognition in various international competitions, particularly in Hong Kong and China. Currently, the company seeks an investment of EUR 2 million to further expand its market presence and develop its diagnostic technology, ultimately aiming to improve the quality of life for cancer patients.
FoodMarble is a company that addresses the challenges faced by nearly one billion individuals with disruptive digestive symptoms. Its flagship product, AIRE, is a personal breath analyzer designed to help users identify which foods are best suited to their unique digestive systems. By utilizing a handheld device and a companion application, AIRE allows individuals to monitor their digestion in real time, leveraging techniques commonly employed in gastroenterology. This innovative approach empowers users to develop personalized diets that can alleviate discomfort and improve their overall well-being. Since its inception, FoodMarble has garnered significant interest, receiving over $500,000 in pre-orders prior to the commencement of device shipments in late 2017. The company aims to create the first comprehensive dataset of its kind, further enhancing users' ability to manage their digestive health.
Kite Medical has created an innovative device designed to detect kidney reflux in children experiencing urinary tract infections. This non-invasive diagnostic solution simplifies the detection process, eliminating the need for complex procedures and hospital visits. Kidney reflux, the most common urological disorder in childhood, affects up to three percent of young children, particularly those aged six months to five years. While the condition may resolve as children grow, undiagnosed and untreated cases can lead to serious consequences, including permanent kidney damage and kidney failure. By providing a straightforward and accessible means of diagnosis, Kite Medical aims to improve the management of this prevalent condition in pediatric patients.
Metabolomic Diagnostics Ltd. is a medical diagnostics company based in Little Island, Ireland, founded in 2011. The company specializes in developing advanced diagnostic solutions that utilize mass spectrometry technology to analyze biomarkers associated with complex diseases. Its primary focus is on providing predictive diagnoses for pre-eclampsia in early pregnancy through a blood test that assesses the risk of this condition, which can lead to serious complications such as hypertension and restricted blood flow to the fetus. Metabolomic Diagnostics has established a pipeline for identifying diagnostic biomarker panels and translating these findings into clinical assays suitable for use in laboratory settings, thus enabling effective disease diagnosis and risk prediction.
Hexafly is a biotechnology company based in Kells, Ireland, that focuses on developing sustainable products derived from the farming of Black Soldier Fly larvae. Established in 2016, Hexafly operates within the circular economy by converting food waste into valuable resources, including insect oil and protein for aquaculture and animal feed, as well as Frass, a plant nutrition compound. The company also produces Chitin, a biopolymer used in pharmaceuticals, cosmetics, and food additives. By offering these products online, Hexafly aims to provide sustainable solutions for the aquaculture, animal feed, and plant nutrition industries, contributing to a more sustainable food system for animals and, ultimately, humans.
Lios, originally founded as Restored Hearing in 2009 by Rhona Togher and Eimear O’Carroll, focuses on combating noise pollution through innovative materials and technologies. The company specializes in developing solutions that reduce the risk of exposure to loud noise and mitigate damage from it. Its flagship product, SoundBounce, is a revolutionary acoustic material designed for various industries, including automotive, aerospace, construction, and power generation. SoundBounce is notably thinner and more effective than traditional soundproofing materials. Additionally, Lios offers SoundRelief, a tinnitus sound therapy app available on both Apple and Android platforms, which provides at-home treatment for ringing in the ears. The app, scientifically validated and CE marked, includes features for tracking tinnitus and has been utilized in over 60 countries, significantly improving users' quality of life. Through these innovations, Lios addresses industry challenges with a commitment to creating a quieter world.
Cell-Free Technology Limited, established in 2017 and located in Cork, Ireland, specializes in the production of cell-free extracts that enable the synthesis of essential biomolecules, such as insulin, odors, bio-compatible color palettes, and fluorescent proteins. This innovative approach allows for cell-free protein expression, facilitating the creation of biological products without the constraints of traditional laboratory settings or regulations related to genetic modification. The company offers ultra low-cost cell-free extracts and kits designed to simplify biological production, making it accessible for various applications outside conventional labs. Additionally, Cell-Free Technology is committed to open-source projects, actively sharing resources to promote wider use and understanding of their technology.
FoodMarble is a company that addresses the challenges faced by nearly one billion individuals with disruptive digestive symptoms. Its flagship product, AIRE, is a personal breath analyzer designed to help users identify which foods are best suited to their unique digestive systems. By utilizing a handheld device and a companion application, AIRE allows individuals to monitor their digestion in real time, leveraging techniques commonly employed in gastroenterology. This innovative approach empowers users to develop personalized diets that can alleviate discomfort and improve their overall well-being. Since its inception, FoodMarble has garnered significant interest, receiving over $500,000 in pre-orders prior to the commencement of device shipments in late 2017. The company aims to create the first comprehensive dataset of its kind, further enhancing users' ability to manage their digestive health.
PowCow is a European brand that produces fat-free, protein, frozen yogurt. It offers 3 flavors, including vanilla, chocolate orange, and passion fruit and mango. Each portion is fat free and contains as little as 150Kcal and 20g protein. PowCow was founded by a dietitian and a sports and exercise nutrition expert Niall Moloney.
PLANTeDIT Limited is a biotech company based in Cork, Ireland, founded in 2017. It specializes in developing advanced plant transformation technologies that utilize CRISPR/Cas9 RNPs for the direct delivery and regeneration of genome-edited plants and biopharmaceuticals. The company focuses on producing non-transgenic, regulatory-free, and sustainable plant products, such as high oleic soya, aimed at consumer health and preferences. PLANTeDIT's innovative approach allows for the creation of DNA-free crops, enabling the production of pure mammalian proteins and human drugs at competitive prices through its genome-edited plant platform. The company also collaborates strategically with Toolgen to enhance its research and development efforts.
MicroSynbiotiX Limited is a biotechnology company based in Cork City, Ireland, that specializes in developing oral vaccines tailored for the aquaculture sector. Founded in 2016, the company focuses on addressing the challenges posed by excessive antibiotic use in farmed fish. Through advancements in algal genomics and molecular biology, MicroSynbiotiX engineers microalgae to produce cost-effective therapeutic proteins and vaccines. This innovative approach utilizes microalgae as an oral delivery system, significantly reducing production costs and labor associated with traditional vaccine methods. The technology aims to decrease fish mortality rates, prevent bacterial and viral diseases that threaten fish stocks, and enhance global food security by providing affordable and user-friendly solutions for aquaculture.
Aylien is an artificial intelligence company based in Wilmington, Delaware, specializing in technologies that enhance machines' understanding of human languages. The firm provides a suite of tools and APIs, including Text Analysis and News APIs, which help users analyze and extract insights from large volumes of human-generated content. Aylien's offerings cater to developers, data scientists, marketers, and academics, enabling them to utilize advanced techniques like natural language processing, machine learning, and image recognition. Among its key products are Talk.ee, which organizes global information, and the AYLIEN App Engine, an open platform for creating micro applications that convert unstructured data into structured formats. Additionally, Aylien offers oTaste, a tool aimed at digitizing human tastes, further demonstrating its commitment to innovative data solutions.
OaCP specializes in healthcare technology focused on enhancing cancer diagnosis through innovative molecular in vitro diagnostics. The company offers patented chemical reagents that significantly reduce both the time and cost associated with DNA testing for cancer, achieving a 97% reduction in time and a 50% reduction in costs. Operating within the competitive USD 1 billion in situ hybridization market, OaCP has recorded USD 100,000 in sales and maintains a strong customer retention rate and gross margin. Its distribution network spans nearly 15 countries, serving hospitals and research and development centers. The company has participated in the RebelBio Accelerator program and secured funding of USD 330,000 from SOS Venture. OaCP has received recognition in various international competitions, particularly in Hong Kong and China. Currently, the company seeks an investment of EUR 2 million to further expand its market presence and develop its diagnostic technology, ultimately aiming to improve the quality of life for cancer patients.
Cell-Free Technology Limited, established in 2017 and located in Cork, Ireland, specializes in the production of cell-free extracts that enable the synthesis of essential biomolecules, such as insulin, odors, bio-compatible color palettes, and fluorescent proteins. This innovative approach allows for cell-free protein expression, facilitating the creation of biological products without the constraints of traditional laboratory settings or regulations related to genetic modification. The company offers ultra low-cost cell-free extracts and kits designed to simplify biological production, making it accessible for various applications outside conventional labs. Additionally, Cell-Free Technology is committed to open-source projects, actively sharing resources to promote wider use and understanding of their technology.
GlowDx is a diagnostics company based in Midleton, Ireland, established in 2015. The company focuses on decentralizing molecular testing through innovative point-of-care technologies, which facilitate local access to diagnostics for tropical diseases. By combining novel molecular technology with effective delivery models, GlowDx aims to improve clinical outcomes while reducing the economic burden on patients and healthcare systems. This approach enhances the quality of life for individuals by ensuring they receive timely and accurate diagnostic information, thereby enabling healthcare providers to offer better-targeted treatments.
SwaLife Biotech discovers small molecules from plants for cosmetics and synthesizes novel anticancer plant alkaloids for medical use targeting DNA damage response.
CyCa OncoSolutions Pvt. Ltd. is a technology company focused on developing molecular devices for the targeted delivery of anticancer drugs directly into cells. Established in 2017 and based in Balasore, India, the company has created innovative drug delivery systems that can cross cellular membrane bilayers, facilitating the introduction of functional molecules such as anticancer agents, water-soluble dyes, and imaging agents into the cytoplasm and other organelles. This technology is particularly beneficial for pharmaceutical and biotechnology companies, as it enhances the brand lifecycle of their drugs and molecules by improving delivery efficacy.
PLANTeDIT Limited is a biotech company based in Cork, Ireland, founded in 2017. It specializes in developing advanced plant transformation technologies that utilize CRISPR/Cas9 RNPs for the direct delivery and regeneration of genome-edited plants and biopharmaceuticals. The company focuses on producing non-transgenic, regulatory-free, and sustainable plant products, such as high oleic soya, aimed at consumer health and preferences. PLANTeDIT's innovative approach allows for the creation of DNA-free crops, enabling the production of pure mammalian proteins and human drugs at competitive prices through its genome-edited plant platform. The company also collaborates strategically with Toolgen to enhance its research and development efforts.
Helixworks is a biotechnology company focused on advancing the field of synthetic biology through innovative enzymatic DNA synthesis methods. The company aims to simplify the complexities of DNA data storage, providing a comprehensive platform that equips developers with essential tools and services. This infrastructure supports various applications, including molecular tagging, digital preservation, and traditional media. Additionally, Helixworks offers advanced barcoding kits designed for multiplexed Next-Generation Sequencing (NGS) applications, which enhance the efficiency and accuracy of sequencing projects. The company's overarching goal is to enable the engineering of living machines, thereby transforming biology into an engineering discipline.
Hexafly is a biotechnology company based in Kells, Ireland, that focuses on developing sustainable products derived from the farming of Black Soldier Fly larvae. Established in 2016, Hexafly operates within the circular economy by converting food waste into valuable resources, including insect oil and protein for aquaculture and animal feed, as well as Frass, a plant nutrition compound. The company also produces Chitin, a biopolymer used in pharmaceuticals, cosmetics, and food additives. By offering these products online, Hexafly aims to provide sustainable solutions for the aquaculture, animal feed, and plant nutrition industries, contributing to a more sustainable food system for animals and, ultimately, humans.
MicroSynbiotiX Limited is a biotechnology company based in Cork City, Ireland, that specializes in developing oral vaccines tailored for the aquaculture sector. Founded in 2016, the company focuses on addressing the challenges posed by excessive antibiotic use in farmed fish. Through advancements in algal genomics and molecular biology, MicroSynbiotiX engineers microalgae to produce cost-effective therapeutic proteins and vaccines. This innovative approach utilizes microalgae as an oral delivery system, significantly reducing production costs and labor associated with traditional vaccine methods. The technology aims to decrease fish mortality rates, prevent bacterial and viral diseases that threaten fish stocks, and enhance global food security by providing affordable and user-friendly solutions for aquaculture.
Intelligent Implants, founded in 2014 in Cork, Ireland, specializes in the development of wireless implantable electronics designed to stimulate, steer, and monitor bone growth. The company focuses on creating electrotherapeutic devices that not only treat diseases but also support the recovery of bone and other tissues. By integrating data, engineering, and medicine, Intelligent Implants aims to deliver innovative, active, and connected medical devices that enhance patient treatment and facilitate decision-making for healthcare professionals. Their technology allows for the acceleration and adjustment of bone growth, enabling healthcare providers to effectively utilize electrotherapeutics to monitor and control patient conditions, ultimately leading to more timely and informed medical interventions.
FruitCubed is a food company based in Cork, Ireland, that addresses food waste by transforming surplus and overripe fruits and vegetables into nutritious products. Founded in 2015, the company specializes in producing fruit-based flavored stock cubes designed to provide individuals with the nutritional benefits of fruits and vegetables. These stock cubes can be refrigerated and used for various culinary applications, allowing consumers to enjoy a refreshing and healthy addition to their meals while contributing to waste reduction.
FruitCubed is a food company based in Cork, Ireland, that addresses food waste by transforming surplus and overripe fruits and vegetables into nutritious products. Founded in 2015, the company specializes in producing fruit-based flavored stock cubes designed to provide individuals with the nutritional benefits of fruits and vegetables. These stock cubes can be refrigerated and used for various culinary applications, allowing consumers to enjoy a refreshing and healthy addition to their meals while contributing to waste reduction.
Intelligent Implants, founded in 2014 in Cork, Ireland, specializes in the development of wireless implantable electronics designed to stimulate, steer, and monitor bone growth. The company focuses on creating electrotherapeutic devices that not only treat diseases but also support the recovery of bone and other tissues. By integrating data, engineering, and medicine, Intelligent Implants aims to deliver innovative, active, and connected medical devices that enhance patient treatment and facilitate decision-making for healthcare professionals. Their technology allows for the acceleration and adjustment of bone growth, enabling healthcare providers to effectively utilize electrotherapeutics to monitor and control patient conditions, ultimately leading to more timely and informed medical interventions.
Helixworks is a biotechnology company focused on advancing the field of synthetic biology through innovative enzymatic DNA synthesis methods. The company aims to simplify the complexities of DNA data storage, providing a comprehensive platform that equips developers with essential tools and services. This infrastructure supports various applications, including molecular tagging, digital preservation, and traditional media. Additionally, Helixworks offers advanced barcoding kits designed for multiplexed Next-Generation Sequencing (NGS) applications, which enhance the efficiency and accuracy of sequencing projects. The company's overarching goal is to enable the engineering of living machines, thereby transforming biology into an engineering discipline.
Metabolomic Diagnostics Ltd. is a medical diagnostics company based in Little Island, Ireland, founded in 2011. The company specializes in developing advanced diagnostic solutions that utilize mass spectrometry technology to analyze biomarkers associated with complex diseases. Its primary focus is on providing predictive diagnoses for pre-eclampsia in early pregnancy through a blood test that assesses the risk of this condition, which can lead to serious complications such as hypertension and restricted blood flow to the fetus. Metabolomic Diagnostics has established a pipeline for identifying diagnostic biomarker panels and translating these findings into clinical assays suitable for use in laboratory settings, thus enabling effective disease diagnosis and risk prediction.
Ageria Ltd. specializes in the production of yogurt enriched with a longevity compound called Spermidine, aimed at promoting healthier aging. Founded in 2015, the company is headquartered in Vienna, Austria, and focuses on naturally engineering yogurt to incorporate beneficial compounds that support human health. Ageria's innovative approach involves modifying yogurt bacteria to enhance the production of health-promoting oxidative compounds. As part of its development process, the company is affiliated with the Indiebio biotech incubator at University College Cork in Ireland, where it continues to refine its product offerings.
Sothic Bioscience Ltd. is a biotech company based in Cork, Ireland, established in 2015. The company focuses on developing LimuleX, a bio-production platform designed to create bio-identical replacements for naturally sourced limulus amebocyte lysate. This innovation aims to eliminate the reliance on the threatened horseshoe crab species in the pharmaceutical quality control supply chain. Sothic Bioscience is currently in the lab bench production phase of a highly specific pyrogen contamination testing reagent. To support scaling up production and market entry, the company is actively raising seed capital, emphasizing its commitment to replacing unsustainable animal sourcing with scalable production of high-quality biomolecules for the pharmaceutical, medical device, and biomedical research sectors.
Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016 and based in Barcelona, Spain, the company specializes in creating non-invasive tests for the in-situ diagnosis of various cancers using patients' blood. It also develops in-vivo diagnosis systems that assist in surgical procedures and monitor patient conditions, alongside therapeutical drugs aimed at treating cancer. Moirai Biodesign's innovative pipeline includes RNA biomarker discovery, the design of plug-and-play bio devices, and advanced platform delivery systems, all aimed at improving early cancer detection and targeted treatment options.
MicroSynbiotiX Limited is a biotechnology company based in Cork City, Ireland, that specializes in developing oral vaccines tailored for the aquaculture sector. Founded in 2016, the company focuses on addressing the challenges posed by excessive antibiotic use in farmed fish. Through advancements in algal genomics and molecular biology, MicroSynbiotiX engineers microalgae to produce cost-effective therapeutic proteins and vaccines. This innovative approach utilizes microalgae as an oral delivery system, significantly reducing production costs and labor associated with traditional vaccine methods. The technology aims to decrease fish mortality rates, prevent bacterial and viral diseases that threaten fish stocks, and enhance global food security by providing affordable and user-friendly solutions for aquaculture.
Hexafly is a biotechnology company based in Kells, Ireland, that focuses on developing sustainable products derived from the farming of Black Soldier Fly larvae. Established in 2016, Hexafly operates within the circular economy by converting food waste into valuable resources, including insect oil and protein for aquaculture and animal feed, as well as Frass, a plant nutrition compound. The company also produces Chitin, a biopolymer used in pharmaceuticals, cosmetics, and food additives. By offering these products online, Hexafly aims to provide sustainable solutions for the aquaculture, animal feed, and plant nutrition industries, contributing to a more sustainable food system for animals and, ultimately, humans.
MilisBio is developing a sugar substitute from protein that will satiate their cravings without harming their health. There is currently no widely available sweetener without at least suspected associated health concerns. In time they intend to apply the same method of protein design to other flavours such as saltiness without salt, bitter taste blockers for medicines and so on.
FoodMarble is a company that addresses the challenges faced by nearly one billion individuals with disruptive digestive symptoms. Its flagship product, AIRE, is a personal breath analyzer designed to help users identify which foods are best suited to their unique digestive systems. By utilizing a handheld device and a companion application, AIRE allows individuals to monitor their digestion in real time, leveraging techniques commonly employed in gastroenterology. This innovative approach empowers users to develop personalized diets that can alleviate discomfort and improve their overall well-being. Since its inception, FoodMarble has garnered significant interest, receiving over $500,000 in pre-orders prior to the commencement of device shipments in late 2017. The company aims to create the first comprehensive dataset of its kind, further enhancing users' ability to manage their digestive health.
Anú Dairy Limited, established in 2016 and based in Cork, Ireland, specializes in producing vitamin K2-rich butter. The company is committed to regenerative agriculture practices, focusing on enhancing soil organic and carbon levels while employing chemical-free organic farming techniques. Anú Dairy utilizes advanced grazing management and soil microbiome analysis to optimize outcomes for farmers, consumers, animal welfare, and the environment. In addition to its butter production, the company develops probiotics aimed at increasing the vitamin K2 content in milk and dairy products, thereby improving the nutritional value of dairy offerings.
Aylien is an artificial intelligence company based in Wilmington, Delaware, specializing in technologies that enhance machines' understanding of human languages. The firm provides a suite of tools and APIs, including Text Analysis and News APIs, which help users analyze and extract insights from large volumes of human-generated content. Aylien's offerings cater to developers, data scientists, marketers, and academics, enabling them to utilize advanced techniques like natural language processing, machine learning, and image recognition. Among its key products are Talk.ee, which organizes global information, and the AYLIEN App Engine, an open platform for creating micro applications that convert unstructured data into structured formats. Additionally, Aylien offers oTaste, a tool aimed at digitizing human tastes, further demonstrating its commitment to innovative data solutions.
GlowDx is a diagnostics company based in Midleton, Ireland, established in 2015. The company focuses on decentralizing molecular testing through innovative point-of-care technologies, which facilitate local access to diagnostics for tropical diseases. By combining novel molecular technology with effective delivery models, GlowDx aims to improve clinical outcomes while reducing the economic burden on patients and healthcare systems. This approach enhances the quality of life for individuals by ensuring they receive timely and accurate diagnostic information, thereby enabling healthcare providers to offer better-targeted treatments.
Learnlode is headquartered in Ireland and is creating a next generation knowledge management and online learning platform. How much of your companies value is built on what your employees know? How much do you spend on training and recruitment to build up that knowledge value? Their platform will help you capture and retain some of the value of that knowledge for your business so you can find it, capture it and share it across your business.
Aranex Biotech is focused on developing hypoallergenic peanuts that do not contain the major allergens typically associated with peanut allergies. The company is currently working on a proof-of-concept at University College Cork in Ireland, where it aims to advance its innovative approach to creating safer peanut products. By addressing the prevalent issue of peanut allergies, Aranex seeks to provide a viable alternative for consumers who are allergic to traditional peanuts, ultimately contributing to improved food safety and accessibility.
Ageria Ltd. specializes in the production of yogurt enriched with a longevity compound called Spermidine, aimed at promoting healthier aging. Founded in 2015, the company is headquartered in Vienna, Austria, and focuses on naturally engineering yogurt to incorporate beneficial compounds that support human health. Ageria's innovative approach involves modifying yogurt bacteria to enhance the production of health-promoting oxidative compounds. As part of its development process, the company is affiliated with the Indiebio biotech incubator at University College Cork in Ireland, where it continues to refine its product offerings.
Sothic Bioscience Ltd. is a biotech company based in Cork, Ireland, established in 2015. The company focuses on developing LimuleX, a bio-production platform designed to create bio-identical replacements for naturally sourced limulus amebocyte lysate. This innovation aims to eliminate the reliance on the threatened horseshoe crab species in the pharmaceutical quality control supply chain. Sothic Bioscience is currently in the lab bench production phase of a highly specific pyrogen contamination testing reagent. To support scaling up production and market entry, the company is actively raising seed capital, emphasizing its commitment to replacing unsustainable animal sourcing with scalable production of high-quality biomolecules for the pharmaceutical, medical device, and biomedical research sectors.
Ouro_botics, founded by Jemma Redmond in Dublin, specializes in developing affordable modular bioprinting technology aimed at researchers in the biotech sector. The company emerged from Redmond's academic exploration of osteoblast adhesion, which led her to realize the potential of bioprinting for advancing medical applications. Ouro_botics addresses the gaps in the market by offering a high-precision 3D bioprinter that achieves an accuracy of 10 microns and supports various types of extruder heads. This versatility allows researchers to experiment with different biomaterials such as gelatine, alginate, chitosan, and keratin, enhancing their ability to conduct tissue growth studies and accelerate medical research. Currently, the company is providing a limited number of development kits available for pre-order, making advanced bioprinting technology accessible to students, biohackers, and researchers.
Ouro_botics, founded by Jemma Redmond in Dublin, specializes in developing affordable modular bioprinting technology aimed at researchers in the biotech sector. The company emerged from Redmond's academic exploration of osteoblast adhesion, which led her to realize the potential of bioprinting for advancing medical applications. Ouro_botics addresses the gaps in the market by offering a high-precision 3D bioprinter that achieves an accuracy of 10 microns and supports various types of extruder heads. This versatility allows researchers to experiment with different biomaterials such as gelatine, alginate, chitosan, and keratin, enhancing their ability to conduct tissue growth studies and accelerate medical research. Currently, the company is providing a limited number of development kits available for pre-order, making advanced bioprinting technology accessible to students, biohackers, and researchers.
Impedans specializes in intelligent sensing platforms for radio-frequency (RF) and plasma process monitoring. Their technology is utilized across various sectors, including semiconductor manufacturing, vacuum coating, medical devices, hard disk production, and aerospace, among others. The company's products support applications such as fundamental research, process development, tool design, process control, and fault detection and classification. By offering high-resolution plasma diagnostics and quality performance, Impedans enables clients to obtain accurate process measurements and address complex processing challenges effectively. Their expertise in RF and plasma systems, combined with internet-enabled sensing capabilities, provides an independent diagnosis of process health, helping customers optimize their operations.
Common Trip is an online ride-sharing platform designed to enhance the daily commuting experience by making it more social and engaging. Users can input trip details, such as vehicle type, trip frequency, and locations, to create a smart trip card that centralizes all relevant information. The platform facilitates real-time communication, providing automated updates when trips start or when drivers are nearby. Users can share their trip details with their network, promoting transparency and encouraging participation in eco-friendly transportation options like carpooling and public transport. Additionally, Common Trip rewards users for their green commuting efforts, allowing them to earn incentives based on the number of sustainable miles traveled.
WhatSalon is a mobile application available for both iPhone and Android devices that facilitates last-minute bookings at local hair and beauty salons. The app simplifies the appointment process, allowing users to browse salons in their vicinity, select desired services, and view available time slots—all through a user-friendly interface. Additionally, WhatSalon provides features such as beautiful imagery and customer reviews, enabling users to evaluate salons before making a booking. This platform connects consumers with both new and familiar stylists, making it easier to secure appointments conveniently, whether on the go or during downtime. WhatSalon operates under WhatSalon Applications Ltd., registered in the Republic of Ireland.
Metabolomic Diagnostics Ltd. is a medical diagnostics company based in Little Island, Ireland, founded in 2011. The company specializes in developing advanced diagnostic solutions that utilize mass spectrometry technology to analyze biomarkers associated with complex diseases. Its primary focus is on providing predictive diagnoses for pre-eclampsia in early pregnancy through a blood test that assesses the risk of this condition, which can lead to serious complications such as hypertension and restricted blood flow to the fetus. Metabolomic Diagnostics has established a pipeline for identifying diagnostic biomarker panels and translating these findings into clinical assays suitable for use in laboratory settings, thus enabling effective disease diagnosis and risk prediction.
Online services such as Facebook, LinkedIn etc. collect huge amounts of data. However their typical user can't benefit from the wealth of information available there! Accessing the data requires advanced programming skills and hours if not days of learning different APIs. Asyncode is the simple way to work with data stored in the cloud or generated by sensors. Users can create their own data solutions by building recipes. A recipe is a set of simple steps that tell our servers where to get data from, what to do with them and how to visualize the result. A basic example would be getting user's followers from Twitter and displaying the location of their last tweet on a map or taking all blog posts from a Tumblr account and, using a text analysis API, tagging automatically each of them.
Makers.TV is a unique 40 day, mentor driven accelerator program, which takes would-be production teams with ideas for new world class TV formats, from the start, right through to a pilot version of the program. Makers.TV culminates in a ‘demo/sales day’ in front of potential customers, from distributors to broadcasters from across the globe and will also feature an industry ‘mentor of honour’ with extensive experience of the Chinese TV marketplace.
Taxworld Ltd., founded in 1996 by Alan Moore, is a pioneering publishing company that specializes in tax legislation and commentary. It has established itself as a leading provider in the field through several innovative offerings, including the first plain English rewrite of Irish tax law and the introduction of the first fully searchable Irish taxation publication. Taxworld also produced the first tax planning book and was the first to make Irish tax publications available on mobile devices. The company serves a diverse clientele of over 5,000 customers, which includes major financial institutions, top accounting and tax practitioners, prominent legal firms, and the Irish Revenue. Additionally, Taxworld offers a web-based publishing platform that delivers tax law, articles, and commentary, further enhancing its role in the tax publication industry.
Metabolomic Diagnostics Ltd. is a medical diagnostics company based in Little Island, Ireland, founded in 2011. The company specializes in developing advanced diagnostic solutions that utilize mass spectrometry technology to analyze biomarkers associated with complex diseases. Its primary focus is on providing predictive diagnoses for pre-eclampsia in early pregnancy through a blood test that assesses the risk of this condition, which can lead to serious complications such as hypertension and restricted blood flow to the fetus. Metabolomic Diagnostics has established a pipeline for identifying diagnostic biomarker panels and translating these findings into clinical assays suitable for use in laboratory settings, thus enabling effective disease diagnosis and risk prediction.
Metabolomic Diagnostics Ltd. is a medical diagnostics company based in Little Island, Ireland, founded in 2011. The company specializes in developing advanced diagnostic solutions that utilize mass spectrometry technology to analyze biomarkers associated with complex diseases. Its primary focus is on providing predictive diagnoses for pre-eclampsia in early pregnancy through a blood test that assesses the risk of this condition, which can lead to serious complications such as hypertension and restricted blood flow to the fetus. Metabolomic Diagnostics has established a pipeline for identifying diagnostic biomarker panels and translating these findings into clinical assays suitable for use in laboratory settings, thus enabling effective disease diagnosis and risk prediction.
Lios, originally founded as Restored Hearing in 2009 by Rhona Togher and Eimear O’Carroll, focuses on combating noise pollution through innovative materials and technologies. The company specializes in developing solutions that reduce the risk of exposure to loud noise and mitigate damage from it. Its flagship product, SoundBounce, is a revolutionary acoustic material designed for various industries, including automotive, aerospace, construction, and power generation. SoundBounce is notably thinner and more effective than traditional soundproofing materials. Additionally, Lios offers SoundRelief, a tinnitus sound therapy app available on both Apple and Android platforms, which provides at-home treatment for ringing in the ears. The app, scientifically validated and CE marked, includes features for tracking tinnitus and has been utilized in over 60 countries, significantly improving users' quality of life. Through these innovations, Lios addresses industry challenges with a commitment to creating a quieter world.
SensiPass Ltd. specializes in developing advanced 3-factor authentication solutions aimed at enhancing digital security for various industries, including energy, transportation, communications, government, and defense. Established in 2013 and headquartered in Dublin, Ireland, the company addresses significant challenges related to identity theft and insider threats by replacing traditional passwords and PINs with a personalized human interaction model. By registering a user's device, biometric data, and a unique interaction, SensiPass generates a sophisticated digital signature that is secure and non-reproducible. This innovative approach allows for quick authentication, providing identity assurance in both digital and physical access scenarios. The company's patented technologies, such as SensiAR™ and ImmersiveID™, cater to immersive environments, reinforcing security for critical infrastructure and utilities. SensiPass has received recognition for its contributions to cybersecurity innovation, including accolades from Deloitte and other industry organizations.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.